EUVIMEDEUVIMED entdecken
Crossref

Formulation and evaluation of sublingual tablet containing trandolapril for the treatment of mild to moderate hypertension

Nikita Yadav, Ravi Sharma, Sumeet Dwivedi, G. N. Darwhekar

BIOCHEMICAL AND CELLULAR ARCHIVES · 31.10.2025 · 26 (1) · 797-801

DOI: 10.51470/bca.2026.26.1.797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 08.11.2025. Verfasst von Nikita Yadav und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study focuses on the formulation and evaluation of sublingual tablets of solid dispersion of Trandolapril, a poorly water-soluble antihypertensive agent, to enhance its solubility, bioavailability, and onset of action. Trandolapril belongs to the class of ACE inhibitors and undergoes extensive first-pass metabolism, limiting its oral bioavailability. To overcome this, solid dispersions of Trandolapril were prepared using hydrophilic carriers by kneading method. These solid dispersions were then incorporated into sublingual tablets using direct compression technique. The prepared tablets were evaluated for precompression parameters (bulk density, tapped density, angle of repose) and post-compression parameters including hardness, friability, weight variation, disintegration time, wetting time, drug content and in vitro dissolution studies. Among all the formulations, the optimized batch demonstrated rapid disintegration within 60 seconds, improved dissolution profile with more than 90% drug release within 10 minutes, and acceptable physicochemical properties. FTIR studies confirmed no significant interaction between the drug and excipients. The developed sublingual tablet of Trandolapril solid dispersion presents a promising approach for improving the solubility and bioavailability of the drug, offering a rapid onset of action beneficial in hypertensive emergencies.

Zitieren

APA

Yadav, N., Sharma, R., Dwivedi, S., & Darwhekar, G. N. (2025). Formulation and evaluation of sublingual tablet containing trandolapril for the treatment of mild to moderate hypertension. BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 797-801. https://doi.org/10.51470/bca.2026.26.1.797

Vancouver

Yadav N, Sharma R, Dwivedi S, Darwhekar GN. Formulation and evaluation of sublingual tablet containing trandolapril for the treatment of mild to moderate hypertension. BIOCHEMICAL AND CELLULAR ARCHIVES. 2025;26(1):797-801. doi:10.51470/bca.2026.26.1.797

BibTeX
@article{Yadav2025,
  author = {Yadav, Nikita and Sharma, Ravi and Dwivedi, Sumeet and Darwhekar, G. N.},
  title = {Formulation and evaluation of sublingual tablet containing trandolapril for the treatment of mild to moderate hypertension},
  journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {797--801},
  doi = {10.51470/bca.2026.26.1.797}
}
Kostenlos starten →